Skip to main content
. 2022 Nov 25;2(1):100516. doi: 10.1016/j.jscai.2022.100516

Figure 2.

Figure 2

Forest plot of in-hospital, short-term (<1 year), 1-year, and midterm mortality in patients with failed bioprostheses who underwent mitral valve-in-valve (MViV) replacement versus those in patients who underwent redo surgical mitral valve replacement (SMVR). OR, odds ratio.